当前位置:首页 - 行情中心 - 珈凯生物(920165) - 财务分析 - 现金流量表

珈凯生物

(920165)

  

流通市值:0.00万  总市值:0.00万
流通股本:0.00万   总股本:0.00万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金71,750,982.55292,186,212.55207,271,449.57140,982,831.41
  收到的税费返还5,982,191.264,374,643.664,830,263.172,555,788.98
  收到其他与经营活动有关的现金945,484.064,548,470.653,509,187.854,189,607.39
  经营活动现金流入小计78,678,657.87301,109,326.86215,610,900.59147,728,227.78
  购买商品、接受劳务支付的现金20,848,085.2384,709,456.6563,120,184.539,795,917.48
  支付给职工以及为职工支付的现金23,917,569.9759,148,394.3848,928,110.3133,604,472.78
  支付的各项税费10,242,234.8636,219,257.8226,116,354.118,760,264.57
  支付其他与经营活动有关的现金8,246,157.5629,502,980.2522,209,607.1513,727,686.16
  经营活动现金流出小计63,254,047.62209,580,089.1160,374,256.06105,888,340.99
  经营活动产生的现金流量净额15,424,610.2591,529,237.7655,236,644.5341,839,886.79
二、投资活动产生的现金流量:
  处置固定资产、无形资产和其他长期资产收回的现金净额116,213.0558,256.6458,256.64292.04
  收到的其他与投资活动有关的现金190,233,112.64378,506,028.26253,336,983.57168,219,870.93
  投资活动现金流入小计190,349,325.69378,564,284.9253,395,240.21168,220,162.97
  购建固定资产、无形资产和其他长期资产支付的现金3,639,730.3514,937,617.0512,890,408.159,983,881.81
  支付其他与投资活动有关的现金160,000,000438,000,000283,000,000168,000,000
  投资活动现金流出小计163,639,730.35452,937,617.05295,890,408.15177,983,881.81
  投资活动产生的现金流量净额26,709,595.34-74,373,332.15-42,495,167.94-9,763,718.84
三、筹资活动产生的现金流量:
  收到其他与筹资活动有关的现金--67,475.24-
  筹资活动现金流入平衡项目--0-
  筹资活动现金流入小计--67,475.24-
  偿还债务支付的现金-200,000200,000200,000
  分配股利、利润或偿付利息支付的现金71,25031,162,471.9931,090,430.3330,996,124.77
  支付其他与筹资活动有关的现金607,0294,812,2004,962,649.992,199,100
  筹资活动现金流出小计678,27936,174,671.9936,253,080.3233,395,224.77
  筹资活动产生的现金流量净额-678,279-36,174,671.99-36,185,605.08-33,395,224.77
四、汇率变动对现金及现金等价物的影响-228,122.2483,978.91133,751.73286,469.55
五、现金及现金等价物净增加额41,227,804.35-18,934,787.47-23,310,376.76-1,032,587.27
  加:期初现金及现金等价物余额58,996,515.8377,931,303.377,931,303.377,931,303.3
  期末现金及现金等价物余额100,224,320.1858,996,515.8354,620,926.5476,898,716.03
补充资料:
  净利润-66,269,300-29,019,222.89
  资产减值准备-351,400-569,148.65
  固定资产和投资性房地产折旧-19,178,200-9,567,191.66
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-19,178,200-9,567,191.66
  无形资产摊销-1,689,300-846,547.68
  长期待摊费用摊销-669,900-268,137.36
  处置固定资产、无形资产和其他长期资产的损失-189,100--
  固定资产报废损失-26,200-26,210.6
  公允价值变动损失--24,700--
  财务费用-332,000--18,783.34
  投资损失--506,000--219,870.93
  递延所得税-317,000--74,787.89
  其中:递延所得税资产减少-371,200--45,835.18
    递延所得税负债增加--54,200--28,952.71
  存货的减少-24,100--5,650,062.37
  经营性应收项目的减少-433,200-7,283,014.35
  经营性应付项目的增加--518,000--1,215,608.7
  其他-2,992,100--
  现金的期末余额---76,898,716.03
  减:现金的期初余额---77,931,303.3
  现金及现金等价物的净增加额--18,934,787.47--1,032,587.27
公告日期2026-04-212026-03-202025-11-102025-08-26
审计意见(境内)标准无保留意见标准无保留意见
TOP↑